Effect of coenzyme Q10 on catalase activity and other antioxidant parameters in streptozotocin-induced diabetic rats

Biological Trace Element Research

Volumn 109, Issue 1, 2006, Pages 25-33

  Modi, Ketan ^a   Santani, D D ^a   Goyal, R K ^a   Bhatt, P A ^a  

^a L M COLLEGE OF PHARMACY   (India)

Author keywords

Antioxidant activity; Coenzyme Q10; Diabetes mellitus; Insulin resistance

Indexed keywords

CATALASE; CHOLESTEROL; FATTY ACID; GLUCOSE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; UBIDECARENONE; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ATHEROGENESIS; CARBOHYDRATE METABOLISM; CHOLESTEROL BLOOD LEVEL; COENZYME; ENZYME ACTIVITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID METABOLISM; LIPID PEROXIDATION; LIVER HOMOGENATE; MALE; NONHUMAN; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA;

EID: 29944435940     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/bter:109:1:025     Document Type: Article

References (29)

1. M. Brownlee, Biochemistry and molecular cell biology of diabetic complications, Nature 414, 813-820 (2001).
2. M. Brownlee, Negative consequence of glycation, Metabolism 49, 9-13 (2000).
3. P. Rosen, P. P. Nawroth, G. King, et al., The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a congress series sponsored by UNESCO-MCBN, the American Diabetic Association, and the German diabetic society, Diabetes 17, 189-212 (2001).
4. I. C. West, Radicals and oxidative stress in diabetes, Diabetes Med. 17, 171-180 (2000).
5. D. Giuglian, A. Ceriello, and G. Paolisso, Diabetes mellitus, hypertension and cardiovascular disease. Which role for oxidative stress? Metabolism 44, 363-368 (1995).
6. A. K. Mohamed, A. Bierhaus, S. Schiekofer, et al., The role of oxidative stress and NFκB activation in late diabetic complications, Biofactors 10, 157-167 (1999).
7. C. D. A. Stehouwer and N. C. Schaper, The pathogenesis of vascular complications of diabetes mellitus. One voice or many? Eur. J. Clin. Invest. 26, 533-543 (1996).
8. M. Yaqoob, A. W. Patrick, P. McClelland, et al., Relationship between markers of endothelial dysfunction, oxidant injury and tubular damage in patients with insulin-dependent diabetes mellitus, Clin. Sci. 85, 557-562 (1993).
9. S. R. Maxwell and H. Thomson, Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus, Eur. J. Clin. Invest. 27, 484-490 (1997).
10. S. A. Santini and G. Marra, Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM, Diabetes 46, 1853-1858 (1997).
11. L. ErnsteerL and G. Dallner, Biochemical, physiological and medical aspects of ubiquinone function, Biochem. Biophys. Acta. 1271, 195-204 (1995).
12. J. Kucharska, Z. Braunova, I. O.uliena, et al., Deficit of coenzyme Q10 in heart and liver mitochondria of rats with Streptozotocin induced diabetes, Physiol. Res. 49, 411-418 (2000).
13. R. Stocker and B. Frei, Endogenous antioxidant defenses in human blood plasma, in Oxidants and Antioxidants, H. Sies, ed., Academic, London, pp. 213-243 (1991).
14. H. Ohkawa, N. Ohis, and K. Yagi, Assay of lipid peroxides in animal tissues by thiobarbituric reaction, Anal. Biochem. 95 351 (1979).
15. H. Mishra, and I. Frodvich, The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, J. Biol. Chem. 247 31-70 (1972).
16. H. Aebi, Catalase in vitro. Methods in Enzymology, L. Packer, ed., Academic, New York Vol. 105, p. 121-126 (1984).
17. E. Beutler and B. Kelly, The effect of sodium on RBC glutathione, J. Experimentia 19, 96 (1963).
18. O. Lowery, N. Rosenbrough, A Farr, et al., Protein measurement with the folin phenol reagent, J. Biol. Chem. 193, 265 (1951).
19. R. Stocker and B. Frei, Endogenous antioxidant defenses in human blood plasma, in Oxidative Stress: Oxidants and Antioxidants, H. Sies, ed., Academic, London, pp. 213-243 (1991).
20. B. Rodrigues, R. K. Goyal, and J. H. McNeill, Effect of hydralazine on STZ-induced diabetic rats: prevention of hyperlipidenia and improvement in cardiac function, J. Pharmacol. Exp. Ther. 237, 292-299 (1986).
21. R. B. Singh, S. N. Shinde, R. K. Chopra, et al., Effect of CoQ10 on experimental atherosclerosis and chemical composition and quality of atheroma in rabbits, Atherosclerosis 148 275-282 (2000).
22. H. Esterbauer, J. Gebicki, and G. Jurgens, The role of lipid peroxidation and antioxidants in oxidative modification of LDL, Free Radical Biol. Med. 13, 341-390 (1992).
23. S. M. Lynch, J. D. Morrow, L. J. Roberts, et al., Formation of non-cyclo oxygenase derived prostanoids, (F2-isoprostares) in plasma and low-density lipoprotein exposed to oxidative stress in vivo, J. Clin. Invest. 93, 998-1004 (1994).
24. A. Rabinovitch, W. L. Suarez-Pinzon, K. Strynadka, et al., Human pancreatic islet β-cell destruction by cytokines involves oxygen free radicals and aldehyde production, J. Clin. Endocri. Metab. 81, 3197-3202 (1996).
25. J. Ludvigsson, Intervention at diagnosis of type I diabetes using antoxidants of photopheresis, Diabetes Metab. Rev. 9, 329-336 (1993).
26. S. Suzuki, Y. Hinkio, and K. Komatu, Oxidative dasmage to mitochondrial DNA and its relationship to diabetes complications, Diabetes Res. Clin. Pract. 45, 161-168 (1999).
27. D. Steinberg, S. Parthasarathy, T. E. Carew, et al., Beyond cholesterol: modification of low-density lipoprotein that increase to atherogenicity, N. Engl. J. Med. 320, 915-924 (1989).
28. 1-integrin, J. Clin. Invest. 103, 613-625 (1999).
29. R. B. Singh, M. A. Niaz, S. S. Rastogi, et al., Effect of hydrosoluble CoQ10 on blood pressure and insulin resistance in hypertensive patients with coronary artery disease, J. Hum. Hypertens. 13, 203-208 (1999).